Abnormal p53‐pattern was observed in 62 of 277 tumors (22%) with highly significant enrichment in the GU subtype compared to Uro (Supporting Information Fig.
← all excerpts
Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma.
1
—
—